PROMOTING ACCESS TO AFRICAN RESEARCH

African Journal of Biotechnology

Log in or Register to get access to full text downloads.

Remember me or Register



Ultrasound sensitizes chemotherapy in chemoresistant ovarian cancers

Y Lou, Y Zhang, H He, Y Liu, P Huang, T Yu

Abstract


Chemotherapy resistance is still a great challenge to the management of ovarian cancers. Using SKOV3/ADR or COC1/DDP subline as a model of adriamycin- or cisplatin-resistance, ultrasonic chemosensitization was investigated. The addition of noncytotoxic insonation led to a higher cell-death rate as compared with a drug alone. Ultrasound sensitized chemotherapy via increasing intracellular drug accumulation, enhancing drug-induced apoptosis and decreasing the threshold dose for cell apoptosis/necrosis. Ultrasound exposure enhanced cisplatin-induced DNA breakages in COC1/DDP cells but did not decrease the level of glutathione-S-transferase. Chemosensitization attributable to insonation was mostly mediated by cavitation. Ultrasonic chemotherapy had the property of a targeted treatment, in that the dose-anticancer effect and dose-toxicity curves differed from those in conventional chemotherapy. The findings indicated that ultrasound was a non-drug modality for sensitizing chemotherapy in refractory ovarian cancers.

Key words: Chemoresistance, ovarian cancer, ultrasound, sonochemotherapy, targeted therapy.




AJOL African Journals Online